Genetic Signatures (GSS)
Genetic Signatures Ltd. engages in the development and commercialization of its proprietary technology 3Base. Its molecular diagnostics 3Base technology provides hospital and pathology laboratories to screen for a wide array of infectious pathogens. The company was founded by Robert J. Birrell, Christopher M. Abbott and Geoffrey Grigg on February 15, 2001 and is headquartered in Darlinghurst, Australia.
|Market Price at 13-12-2017||$0.34|
|Price to Earnings Ratio||-13.09|
|Market Capitalisation||$33.40 (million)|
|Return on Equity (ROE)||-65.38%|